Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
boston top stories
3
×
life sciences
national blog main
boston
clinical trials
national top stories
ally bridge group
alnylam pharmaceuticals
beijing
big data analytics
blackrock
brii bio
brii biosciences
cancer
casdin capital
china
codiak biosciences
cutaneous t-cell lymphoma
deals
diabetic nephropathy
eventide asset management
exosome
focal segmental glomerulosclerosis
glaxosmithkline
goldfinch bio
gsk
hepatitis b
irving investors
jay ghosh
jazz pharmaceuticals
new york blog main
raleigh-durham
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
sarepta therapeutics
schroeder adveq
software
What
medicines
3
×
million
3
×
new
3
×
biosciences
bio’s
drug
ipo
adds
alliance
analysis
areas
based
begin
bio
biotech
brii
bring
brings
bubbles
cells
class
clinical
codiak
company
develop
disease
diseases
earlier
employing
exosome
exosomes
formed
fund
genetic
goldfinch
hepatitis
infectious
kidney
later
launched
Language
unset
Current search:
medicines
×
photo
×
new
×
million
×
" boston top stories "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline